CBG Oil Market Scope
Cannabigerol (CBG) is a type of cannabinoid obtained from the cannabis plant. It’s often referred to as the mother of all cannabinoids. This is because other cannabinoids are derived from cannabigerol acid (CBGA), an acidic form of CBG. CBG is derived from young cannabis plants because they contain higher amounts of CBG than fully developed plants. Some strains of cannabis like White CBG, Super Glue CBG, and Jack Frost CBG also have higher CBG content than other strains. These strains are specifically cultivated to produce higher quantities of CBG.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | High Tide Inc. (Fab Nutrition, LLC) (United States), CBDistillery (United States), Medterra CBD (United States), NuLeaf Naturals (United States), Lazarus Naturals (United States), Premium Jane (United States), Upstate Elevator Supply Co. (United States), Plain Jane (United States), Dosist (United States) and Bluebird Botanicals (United States) |
CAGR | % |
Big players have been taking initiative in clinical trials and production of CBG oil. The trials done on animal have been showing very positive response and thus has many health benefits the awareness is driving the market and has brought many opportunities for new players. Players have been launching new flavors and products to grab the opportunities. There have also been mergers and acquisitions to hold a better position in the market and have better resources for further development. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global CBG Oil market throughout the predicted period.
High Tide Inc. (Fab Nutrition, LLC) (United States), CBDistillery (United States), Medterra CBD (United States), NuLeaf Naturals (United States), Lazarus Naturals (United States), Premium Jane (United States), Upstate Elevator Supply Co. (United States), Plain Jane (United States), Dosist (United States) and Bluebird Botanicals (United States) are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global CBG Oil market by Type , by Application (Skincare treatment, Mental Health treatment, Physical Health treatment and Other) and Region with country level break-up.
On the basis of geography, the market of CBG Oil has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In May 2021 High Tide Inc. a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories is pleased to announce that it has completed the acquisition of Fab Nutrition, LLC, operating as FABCBD ("FABCBD") thus meaningfully increasing its presence within the U.S. e-commerce marketplace for hemp-derived CBD products.
June 2022 FAB CBD has just unveiled another exciting product in their already impressive lineup, as well as expanding their CBG oil flavor profile. Taking feedback from current and potential customers has resulted in an unflavored CBD+CBG oil, and a unique vegan soft gel that delivers not only CBD, but also equal parts CBN, CBC, and CBG.
All hemp-derived cannabinoids are legal under the 2018 Farm Bill, provided they’re sourced from hemp plants carrying no more than 0.3% THC. If the THC percentage is above 0.3%, hemp plants are categorized as marijuana, which is a controlled substance under Schedule I of the CSA. Marijuana derivatives are also controlled substances, as are synthetic cannabinoids.
Influencing Trend:
Growing R&D for Better Production of CBG Oil.
Market Growth Drivers:
Rising Adoption and Awareness about Health Benefits.
Challenges:
CBG Is Found at a Low Rate in Grown Plants.
Restraints:
Government Regulations in Countries for Cannabis Production.
Opportunities:
The initiative by Big Players for Initiating Clinical Trials and Production.
Key Target Audience
Pharmaceutical companies, Agriculture, New Entrants and Investors, Legalized Cannabis Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others